Global point of care
Global point of care
There are approximately 1.2 million Americans that have HIV of which 13% do not know their HIV status. The underdiagnosed portion of the HIV community leads to an alarming 40% of the new infections. It is critical to reduce barriers to testing so that these people can be identified so as to further reduce transmission rates.
This webinar will discuss HIV testing in nontraditional settings as it not only improves access but may be the only option for some people to be tested due to limited healthcare options. Identification of new cases will not only reduce new HIV transmission, but will also improve medical outcomes by connecting individuals with early treatment.
Dr. Aniruddha Hazra, MD
Associate Professor, Section of Infectious Diseases and Global Health Medical Director, UCM Sexual Wellness Clinic University of Chicago Chicago, IL USA
Dr. Hazra’s clinical and research interests center on sexually transmitted infections and their impact on sexual and gender minorities as well as other vulnerable populations living on the South Side of Chicago. These interests are complemented by his clinical work in complex HIV management, PrEP care, hepatitis C management, gender affirming hormone therapy, high-resolution anoscopy, treatment of opioid use disorder, and medical education. As a clinical ambassador of CDC's Let Stop HIV Together Campaign, he is passionate about equitable health care delivery to LGBTQ people of color.
Dr. Gregory Hirsch, MD, FACOG OB/GYN and Complex Family Planning
Chief Medical Officer Planned Parenthood of Northern, Central, and Southern New Jersey, USA.
Dr. Hirsch is dual board-certified in Obstetrics & Gynecology and Complex Family Planning. Since 2011, he has served as Chief Medical Officer for Planned Parenthood of Northern, Central, and Southern New Jersey, overseeing 17 clinics that conduct around 20,000 point-of-care HIV tests annually and provide STI prevention and treatment services including HIV PrEP, PEP, and Doxy as PEP through their “Get Yourself Tested” and other programs. Dr. Hirsch retired from private practice in 2023 after 25 years of service. He earned his BS from Cornell University and his MD from Stony Brook Medical School, then completed his residency at Jersey Shore Medical Center in Neptune, New Jersey. Throughout his career, Dr. Hirsch has been dedicated to expanding comprehensive reproductive healthcare and improving public health outcomes.
Physicians
A Leader in Rapid Point-of-care Diagnostics.
©2024 Abbott. All rights reserved. Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.
This website is governed by applicable U.S. laws and governmental regulations. The products and information contained herewith may not be accessible in all countries, and Abbott takes no responsibility for such information which may not comply with local country legal process, regulation, registration and usage.
Your use of this website and the information contained herein is subject to our Website Terms and Conditions and Privacy Policy. Photos displayed are for illustrative purposes only. Any person depicted in such photographs is a model. GDPR Statement
Not all products are available in all regions. Check with your local representative for availability in specific markets. For in vitro diagnostic use only. For i-STAT test cartridge information and intended use, refer to individual product pages or the cartridge information (CTI/IFU) in the i-STAT Support area.
Abbott - A Leader in Rapid Point-of-Care Diagnostics.